From what I can find, although they have left a small component of the bio-tech in the company, that is not the direction they are heading with organic growth and future acquisitions.
I would pay attention to the COO of this company. I have a feeling he's the one with the new vision and ability to turn this situation around.
News 
Market Data 
Discover 
